SynthesisCytotherapy2022

Mesenchymal stem/stromal cell-based therapies for COVID-19: First iteration of a living systematic review and meta-analysis: MSCs and COVID-19.

Aidan M Kirkham et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.